Prescription medication · Azapirone Anxiolytic

buspirone

Also sold as BuSpar. Buspirone is used to manage anxiety disorders.

Data updated 2026-05-15

10,228
FDA reportsModerately reported
17
InteractionsSeveral interactions
2
Recall records

What the data shows

buspirone (BuSpar) is a prescription Azapirone Anxiolytic, reported less often than most tracked drugs (10,228 FDA reports), with 17 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

buspirone (BuSpar) is a prescription Azapirone Anxiolytic. Buspirone is used to manage anxiety disorders.

Buspirone is a medicine that can help manage anxiety disorders. It can also provide short-term relief from anxiety symptoms.

Drug Pricing (NADAC)

Generic Price

$0.03/unit

Generic Available

Yes (15 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

NADAC price trail: BUSPIRONE HCL 10 MG TABLET

Same CMS presentation as the headline generic unit price above (2 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +0.5% vs prior release.

Effective NADAC / unit vs prior NDCs
May 22, 2024 $0.0285/EA - 1
December 18, 2024 $0.0286/EA +0.5% 33
Compare with Another Drug → Full Side Effects Report →

What it does

Buspirone is used to manage anxiety disorders.

Common side effects

Dizziness, Nausea, Headache

Key warnings

You should not take buspirone if you are taking a monoamine oxidase inhibitor (MAOI) antidepressant or have taken one in the past 14 days.

The sections below are summarized in plain English from buspirone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Buspirone affects certain chemicals in your brain that may be unbalanced. This helps to reduce anxiety. It is different from other anxiety medicines like benzodiazepines.

Side Effects (from patient reports)

Based on 10,228 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for buspirone, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for buspirone each year to the FDA Adverse Event Reporting System (FAERS).

05001,0001,500 200320062009201220152018202120242025 1,207

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where buspirone sits

buspirone has more FDA adverse-event reports than 40% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is buspirone; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 10,228 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.

Total Reports

10,228

Reports Mentioning Death

694

6.8% of reports — not proof of cause

Hospitalization Reports

2,354

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 7,174 (75%)
Male 2,427 (25%)

Age Distribution

0–17 93
18–44 1,707
45–64 2,197
65–74 853
75+ 525

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 FATIGUE 759
2 NAUSEA 744
3 HEADACHE 675
4 ANXIETY 636
6 PAIN 541
7 DYSPNOEA 519
8 DEPRESSION 477
9 DIZZINESS 472
10 DIARRHOEA 465
12 FALL 389
14 VOMITING 323
15 MALAISE 321
16 INSOMNIA 319
17 ARTHRALGIA 313
18 FEELING ABNORMAL 312

Reactions in Death Reports

COMPLETED SUICIDE 244
DEATH 211
TOXICITY TO VARIOUS AGENTS 83
CARDIAC ARREST 53
CARDIO-RESPIRATORY ARREST 46
RESPIRATORY ARREST 40
DYSPNOEA 33
OVERDOSE 33
NAUSEA 28
DRUG ABUSE 27

Reactions in Hospitalization Reports

DYSPNOEA 223
NAUSEA 209
FALL 204
PNEUMONIA 199
FATIGUE 191
PAIN 176
HEADACHE 172
ANXIETY 162
DIZZINESS 149
HOSPITALISATION 143

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

You should not take buspirone if you are taking a monoamine oxidase inhibitor (MAOI) antidepressant or have taken one in the past 14 days. Do not start buspirone if you are being treated with linezolid or intravenous methylene blue because of the risk of serotonin syndrome. Serotonin syndrome is a very serious condition.

Known Drug Interactions

Product Clinical Comment on Concomitant Use [See Contraindications (4.1)] ; Predominant Effect/Risk [Hypertensive Reaction (HR) [See Warnings and Precautions (5.3)] ; or Serotonin Syndrome (SS) [See Warnings and Precautions (5.7)] ] Altretamine Use with caution If not otherwise specified in this table, consider avoiding concomitant use (see also information on medication-free intervals , use agent at the lowest appropriate dose, monitor for effects of the interaction, advise the patient to report potential effects, and be prepared to discontinue the agent and treat effects of the...

Mechanism: Combining these medications can cause a dangerous spike in blood pressure or a serious condition called serotonin syndrome.

moderate ziprasidone

Risk of serotonin syndrome with concomitant therapy with other serotonergic drugs such as SNRIs, SSRIs, triptans, tricyclic antidepressants, opioids, lithium, tryptophan, buspirone, amphetamines, and St.

Mechanism: Both of these drugs increase a chemical in the brain called serotonin. Having too much serotonin can lead to a dangerous condition called serotonin syndrome.

Other Serotonergic Drugs Clinical Impact: Concomitant use of citalopram and other serotonergic drugs (including other SSRIs, SNRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.

Mechanism: Both of these medications increase a brain chemical called serotonin. Using them together can cause serotonin levels to rise too high.

buspirone, diazepam, estazolam, zolpidem ↑ sedatives/hypnotics Titration is recommended when co-administering darunavir/ritonavir with sedatives/hypnotics metabolized by CYP3A and a lower dose of the sedatives/hypnotics should be considered with monitoring for adverse events.

Mechanism: Darunavir blocks the enzyme that breaks down buspirone, which can lead to higher levels of the medication in your blood.

Examples other SNRIs, SSRIs, triptans, tricyclic antidepressants, opioids, lithium, buspirone, amphetamines, tryptophan, and St.

Mechanism: Both of these medications increase a brain chemical called serotonin, which can cause an additive effect.

Check all your medications →

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

Can I take buspirone with other anxiety medications?
Talk to your doctor before taking buspirone with other medications.
How long does it take for buspirone to start working?
It may take several weeks for buspirone to start working.
Can I drink alcohol while taking buspirone?
Talk to your doctor about drinking alcohol while taking buspirone.
Will buspirone make me sleepy?
Buspirone can cause drowsiness in some people.
Can I stop taking buspirone suddenly?
Talk to your doctor before stopping buspirone. Stopping suddenly may cause withdrawal symptoms.
Does buspirone have any drug interactions?
Yes, buspirone can interact with other medications. Tell your doctor about all the medicines you take.
Can I drive while taking buspirone?
Buspirone can cause dizziness or drowsiness, so be careful when driving or operating machinery.
What should I do if I experience side effects?
Tell your doctor if you experience any side effects while taking buspirone.
Is buspirone addictive?
Buspirone is not considered to be addictive like some other anxiety medications.
How often will I see my doctor while taking buspirone?
Your doctor will determine how often you need to be seen while taking buspirone.
What are the common side effects of buspirone?
The registry lists Dizziness, Nausea, Headache, Nervousness, Lightheadedness among the most-reported FAERS reaction terms for buspirone. The compiled record contains 10,228 FDA adverse-event reports. These counts are not an individual symptom assessment.
Does buspirone interact with other medications?
The registry has 17 documented interaction rows for buspirone. Notable source-record pairings include tranylcypromine, ziprasidone, citalopram. These rows are not a complete medication review.
What drug class is buspirone?
buspirone belongs to the Azapirone Anxiolytic drug class. It requires a prescription (Rx). Buspirone is used to manage anxiety disorders.
What pregnancy or breastfeeding source fields are listed for buspirone?
The FDA label for buspirone contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has buspirone been recalled?
There are 2 recalls associated with buspirone products. Subpotent drug. Check the recalls section below for full details and affected products.

Active Recalls

Class III April 13, 2026

Subpotent drug

Unichem Pharmaceuticals USA Inc.

Class II March 16, 2023

CGMP Deviations

Northwind Pharmaceuticals LLC

Other drugs grouped near buspirone - same-class peers and common alternatives.

Compare buspirone vs acamprosate side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for buspirone: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

Save on buspirone

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for buspirone

The FDA label for buspirone (sold under brand names such as BuSpar) classifies it as a prescription-only medication in the Azapirone Anxiolytic class. Buspirone is used to manage anxiety disorders. Official labeling lists 6 commonly reported side effects, including Dizziness, Nausea, Headache.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 10,228 voluntary reports. The database also lists 17 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.03.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 2 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: May 3, 2019

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page